INSM logo
NASDAQ · INSMBiotechnologyUpdated Nov 4, 2026

Insmed Incorporated ROE

Profitability, historical returns, and peer comparisons.

The ROE as of November 2026 (TTM) for Insmed Incorporated (INSM) is -82.75%

According to Insmed Incorporated’s latest financial reports and current stock price. The company's current ROE is -82.75%. This represents a change of 297.73% compared to the average of -20.80% of the last 4 quarters.

Insmed Incorporated (INSM) Historical ROE (quarterly & annually)

How has INSM ROE performed in the past?

The mean historical ROE of Insmed Incorporated over the last ten years is -144.75%. The current -82.75% ROE has changed -42.83% with respect to the historical average. Over the past ten years (40 quarters), INSM's ROE was at its highest in in the September 2022 quarter at 437.75%. The ROE was at its lowest in in the June 2024 quarter at -774.41%.

Quarterly (TTM)
Annual

Average

-144.75%

Median

-110.35%

Minimum

-547.50%

Maximum

225.83%

Insmed Incorporated (INSM) ROE by Quarter and Year

Discovering the peaks and valleys of Insmed Incorporated ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 417.04%

Maximum Annual ROE = 225.83%

Minimum Annual Increase = -241.79%

Minimum Annual ROE = -547.50%

Quarterly (TTM)
Annual
YearROEChange
2025-172.78%-46.04%
2024-320.20%-241.79%
2023225.83%-141.25%
2022-547.50%417.04%
2021-105.89%-0.66%
2020-106.60%9.67%
2019-97.20%-37.58%
2018-155.70%191.82%
2017-53.36%-53.24%
2016-114.11%200.94%

Insmed Incorporated (INSM) Average ROE

How has INSM ROE performed in the past?

The current ROE of Insmed Incorporated (INSM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-89.05%

5-year avg

-184.11%

10-year avg

-144.75%

Insmed Incorporated (INSM) ROE vs. Peers

How is INSM’s ROE compared to its peers?

Insmed Incorporated’s ROE is less than United Therapeutics Corporation (19.18%), greater than Avalyn Pharma Inc. Common Stock (-83.23%), greater than Pulmatrix, Inc. (-109.26%), less than Liquidia Corporation (149.64%), less than Theravance Biopharma Inc (19.40%),

Build a custom stock screener for Insmed Incorporated (INSM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Insmed Incorporated using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Insmed Incorporated (INSM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Insmed Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Insmed Incorporated's ROE?

How is the ROE calculated for Insmed Incorporated (INSM)?

What is the highest ROE for Insmed Incorporated (INSM)?

What is the 3-year average ROE for Insmed Incorporated (INSM)?

What is the 5-year average ROE for Insmed Incorporated (INSM)?

How does the current ROE for Insmed Incorporated (INSM) compare to its historical average?